^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Drug:everolimus (mTOR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Hodgkin lymphoma: Subsequent options…Everolimus